Stay updated on Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial
Sign up to get notified when there's something new on the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page.

Latest updates to the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision history updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no visible changes to study details or navigation were observed.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision: v3.4.2 was added to the page footer. Revision: v3.4.1 was removed.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision history updated: a new entry for v3.4.1 was added and the existing entry for v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded UI controls to show/hide the glossary (Show glossary / Hide glossary). Updated metadata labels and version information, including Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, with capitalization adjustments.SummaryDifference0.3%

- Check77 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No visible changes to the study information on the page.SummaryDifference0.1%

Stay in the know with updates to Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page.